These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 190887)

  • 1. Exogenous estrogen and endometrial carcinoma: case-control and incidence study.
    McDonald TW; Annegers JF; O'Fallon WM; Dockerty MB; Malkasian GD; Kurland LT
    Am J Obstet Gynecol; 1977 Mar; 127(6):572-80. PubMed ID: 190887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exogenous estrogens and endometrial cancer.
    Gordan GS; Greenberg BG
    Postgrad Med; 1976 Jun; 59(6):66-77. PubMed ID: 778818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The epidemiology of endometrial cancer in young women.
    Henderson BE; Casagrande JT; Pike MC; Mack T; Rosario I; Duke A
    Br J Cancer; 1983 Jun; 47(6):749-56. PubMed ID: 6860544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endometrial cancer and estrogen use. Report of a large case-control study.
    Antunes CM; Strolley PD; Rosenshein NB; Davies JL; Tonascia JA; Brown C; Burnett L; Rutledge A; Pokempner M; Garcia R
    N Engl J Med; 1979 Jan; 300(1):9-13. PubMed ID: 213722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of long-term estrogen replacement therapy. II. Neoplasia.
    Hammond CB; Jelovsek FR; Lee KL; Creasman WT; Parker RT
    Am J Obstet Gynecol; 1979 Mar; 133(5):537-47. PubMed ID: 220875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogens and endometrial carcinoma.
    Gray LA; Christopherson WM; Hoover RN
    Obstet Gynecol; 1977 Apr; 49(4):385-9. PubMed ID: 193072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of exogenous estrogen therapy and endometrial cancer.
    Jelovsek FR; Hammond CB; Woodard BH; Draffin R; Lee KL; Creasman WT; Parker RT
    Am J Obstet Gynecol; 1980 May; 137(1):85-91. PubMed ID: 7369293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case-control study of cancer of the endometrium.
    Kelsey JL; LiVolsi VA; Holford TR; Fischer DB; Mostow ED; Schwartz PE; O'Connor T; White C
    Am J Epidemiol; 1982 Aug; 116(2):333-42. PubMed ID: 7114042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of estrogens and progesterone in the etiology and prevention of endometrial cancer: review.
    Gambrell RD; Bagnell CA; Greenblatt RB
    Am J Obstet Gynecol; 1983 Jul; 146(6):696-707. PubMed ID: 6307050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benign breast tumor and estrogenic hormones: a population-based retrospective study.
    Nomura A; Comstock GW
    Am J Epidemiol; 1976 May; 103(5):439-44. PubMed ID: 179318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of thyroid cancer in women in relation to reproductive and hormonal factors.
    McTiernan AM; Weiss NS; Daling JR
    Am J Epidemiol; 1984 Sep; 120(3):423-35. PubMed ID: 6475918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exogenous estrogens and endometrial cancer: a case-control study and assessment of potential biases.
    Spengler RF; Clarke EA; Woolever CA; Newman AM; Osborn RW
    Am J Epidemiol; 1981 Oct; 114(4):497-506. PubMed ID: 7304580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Estrogen therapy and carcinoma of the endometrium (author's transl)].
    Völker W; Kannengiesser U; Majewski A; Vasterling HW
    Geburtshilfe Frauenheilkd; 1978 Sep; 38(9):735-43. PubMed ID: 210085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Menopausal estrogens and breast cancer.
    Hoover R; Gray LA; Cole P; MacMahon B
    N Engl J Med; 1976 Aug; 295(8):401-5. PubMed ID: 180409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of endometrial cancer in relation to the use of oral contraceptives.
    Weiss NS; Sayvetz TA
    N Engl J Med; 1980 Mar; 302(10):551-4. PubMed ID: 7351890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk.
    Spicer DV; Ursin G; Parisky YR; Pearce JG; Shoupe D; Pike A; Pike MC
    J Natl Cancer Inst; 1994 Mar; 86(6):431-6. PubMed ID: 8120917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen replacement therapy and the risk of breast cancer: results from the case-control surveillance study.
    Kaufman DW; Palmer JR; de Mouzon J; Rosenberg L; Stolley PD; Warshauer ME; Zauber AG; Shapiro S
    Am J Epidemiol; 1991 Dec; 134(12):1375-85; discussion 1396-401. PubMed ID: 1663700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of endometrial cancer.
    Voigt LF; Weiss NS
    Cancer Treat Res; 1989; 49():1-21. PubMed ID: 2577197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for adenomatous endometrial hyperplasia: a case-control study.
    Kreiger N; Marrett LD; Clarke EA; Hilditch S; Woolever CA
    Am J Epidemiol; 1986 Feb; 123(2):291-301. PubMed ID: 3946378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoplasia and hormonal contraception.
    Huggins GR
    Clin Obstet Gynecol; 1981 Sep; 24(3):903-25. PubMed ID: 7026111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.